We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Donor Plasma Screened for Viral Antibodies

By LabMedica International staff writers
Posted on 02 May 2011
An enzyme immunoassay kit revealed that a proportion of blood donors in France have been exposed to the Toscana virus (TOSV). More...


The presence of immunoglobulin G (IgG) and IgM against TOSV in the plasma of the donors suggests a potential risk for transmitting the virus through blood transfusion or organ transplantation.

Scientists at the University of the Mediterranean, (Marseille, France), tested the plasma collected from 729 blood donors in seven French territorial divisions during the summer of 2007 for the presence of TOSV antibodies. A commercial enzyme immunoassay (EIA) kit was developed by using the recombinant nucleocapsid (N) protein of TOSV. This serologic test had been validated in a previous study that revealed high specificity and sensitivity.

The results showed that 84/729 (11.5%) plasma samples were positive for IgG against TOSV N protein. Twenty-four (3.3%) plasma samples were positive for IgM and five (0.7%) were positive for both IgG and IgM. To confirm the results, the IgG-positive samples were further subjected to Western blot (WB) analysis by using the TOSV isolate H/IMTSSA infected cell lysate. In 233 (32%) of the samples, protein of molecular mass compatible with that of the N protein was detected.

To detect TOSV ribonucleic acid (RNA), the investigators processed IgM-positive plasma samples by reverse transcription–polymerase chain reaction (RT-PCR). The finding of IgM is an indication of a recent exposure to the virus and hence its possible presence in blood. The RT-PCR did not detect any viral RNA in the samples. These negative results could indicate either cleared viremia or a low viral load, below the sensitivity limit of the test. TOSV prevalence in Corsica, an island in the Mediterranean Sea, was unexpectedly high. In this region, 10 of the 115 donors, (8.7%), of the population sampled showed an IgG- or IgM-positive response. In the other districts, the IgM seroprevalence did not exceed 4.4%.

The commercial enzyme immunoassay kit used is known as the EIA Enzywell Toscana virus IgG and IgM, and produced by DIESSE Diagnostica Senese S.p.A.; Siena, Italy).

Toscana virus is an arthropod-borne RNA virus (family Bunyaviridae and genus Phlebovirus) transmitted by phlebotomine sand flies in Mediterranean countries. TOSV causes acute meningitis and meningoencephalitis in patients. The study was published in May 2011, in the journal Emerging Infectious Diseases.

Related Links:
University of the Mediterranean
DIESSE Diagnostica Senese S.p.A



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.